These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 27121524)

  • 1. Adherence to anti-retroviral drugs.
    Roy MP
    Indian J Med Res; 2016 Feb; 143(2):245. PubMed ID: 27121524
    [No Abstract]   [Full Text] [Related]  

  • 2. Beginning antiretroviral therapy for patients with HIV.
    Johnson JA; Sax PE
    Infect Dis Clin North Am; 2014 Sep; 28(3):421-38. PubMed ID: 25151564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral therapy: toxicity and adherence.
    Nadkar MY; Bajpai S
    J Assoc Physicians India; 2009 May; 57():375-6. PubMed ID: 19634282
    [No Abstract]   [Full Text] [Related]  

  • 4. Adverse interactions with antiretroviral agents: focus on recreational and addiction drugs.
    Vassilev ZP; Marcus SM
    AIDS Read; 2004 Feb; 14(2):96. PubMed ID: 15083804
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiretroviral drugs and liver injury.
    Soriano V; Puoti M; Garcia-Gascó P; Rockstroh JK; Benhamou Y; Barreiro P; McGovern B
    AIDS; 2008 Jan; 22(1):1-13. PubMed ID: 18090386
    [No Abstract]   [Full Text] [Related]  

  • 6. Subclinical contractility impairment in HIV-infected patients: dependence on the class of antiretroviral drugs.
    Mercuro G; Cadeddu C; Nocco S; Deidda M; Mercuro S; Piano P; Ortu F; Manconi PE
    Int J Cardiol; 2013 Sep; 168(2):1538-9. PubMed ID: 23287696
    [No Abstract]   [Full Text] [Related]  

  • 7. Aggressive worsening of Sézary syndrome during early antiretroviral therapy.
    Lehloenya RJ; Shebe K; Hlela C; Dlamini S; Mankahla A; Lapiner V; Meintjes G; Todd G
    AIDS; 2013 Mar; 27(6):1035-1036. PubMed ID: 23698068
    [No Abstract]   [Full Text] [Related]  

  • 8. The influence of symptom experiences and attributions on adherence to highly active anti-retroviral therapy (HAART): a six-month prospective, follow-up study.
    Cooper V; Gellaitry G; Hankins M; Fisher M; Horne R
    AIDS Care; 2009 Apr; 21(4):520-8. PubMed ID: 19401867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular risk and body-fat abnormalities in HIV-infected adults.
    Grinspoon S; Carr A
    N Engl J Med; 2005 Jan; 352(1):48-62. PubMed ID: 15635112
    [No Abstract]   [Full Text] [Related]  

  • 10. Case files from the Bellevue Hospital Center at New York University--lipoatrophy following long-term antiretroviral therapy.
    Daskalakis D; Aberg JA
    MedGenMed; 2005 Oct; 7(4):9. PubMed ID: 16614631
    [No Abstract]   [Full Text] [Related]  

  • 11. Preconception antiretroviral therapy and birth defects: what is needed?
    Bulterys M; Berry RJ; Watts DH
    AIDS; 2014 Nov; 28(18):2777-80. PubMed ID: 25493603
    [No Abstract]   [Full Text] [Related]  

  • 12. Targeting JNK to prevent antiretroviral neuropathy.
    Galeotti N
    Oncotarget; 2017 Feb; 8(8):12546-12547. PubMed ID: 28179580
    [No Abstract]   [Full Text] [Related]  

  • 13. What is the risk of major congenital abnormalities among women on antiretroviral therapy?
    Zash RM; Williams P; Holmes LB
    AIDS; 2018 Jan; 32(3):403-404. PubMed ID: 29309347
    [No Abstract]   [Full Text] [Related]  

  • 14. Considerations on the potential teratogenic effects of antiretroviral therapy.
    Meli M; Vicidomini S; Bartoloni A
    Intern Emerg Med; 2006; 1(3):249-50. PubMed ID: 17120478
    [No Abstract]   [Full Text] [Related]  

  • 15. Once-daily antiretroviral therapy in a cohort of HIV-infected children and adolescents.
    Jiménez-Montero B; Beceiro J; de José-Gómez MI; González-Tomé MI; Gurbindo-Gutierrez D; Martínez-Pérez J; Mellado-Peña MJ; Navarro-Gómez ML; Roa-Francia MA; Rojo-Conejo P; Saavedra-Lozano J; Jiménez de Ory S; Ramos-Amador JT;
    Pediatr Infect Dis J; 2014 Oct; 33(10):1052-4. PubMed ID: 24747153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between atazanavir plasma levels and renal function in HIV-positive individuals on antiretroviral therapy with undetectable viral load.
    Luz AJ; Poeta J; Linden R; Antunes MV; Caminha LI; Callegari-Jacques SM; Sprinz E
    Int J Antimicrob Agents; 2013 May; 41(5):497-8. PubMed ID: 23453620
    [No Abstract]   [Full Text] [Related]  

  • 17. Post-ART Symptoms Were Not the Problem: A Qualitative Study on Adherence to ART in HIV-Infected Patients in a Mozambican Rural Hospital.
    Maixenchs M; Boene H; Anselmo R; Mindu C; Alonso P; Menéndez C; Macete E; Pool R; Letang E; Naniche D; Munguambe K
    PLoS One; 2015; 10(9):e0137336. PubMed ID: 26332680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipokine profiles and lipodystrophy in HIV-infected children during the first 4 years on highly active antiretroviral therapy.
    Resino S; Micheloud D; Lorente R; Bellon JM; Navarro ML; Munoz-Fernandez MA
    HIV Med; 2011 Jan; 12(1):54-60. PubMed ID: 20497248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended release tacrolimus and antiretroviral therapy in a renal transplant recipient: so extended!
    Morelle J; Goffin E; Wallemacq P; De Meyer M; Yombi JC; Mourad M; Kanaan N
    Transpl Int; 2010 Oct; 23(10):1065-7. PubMed ID: 20477995
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of Pill Burden on Adherence, Risk of Hospitalization, and Viral Suppression in Patients with HIV Infection and AIDS Receiving Antiretroviral Therapy.
    Scott Sutton S; Magagnoli J; Hardin JW
    Pharmacotherapy; 2016 Apr; 36(4):385-401. PubMed ID: 26923931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.